The use of skin testing in the investigation of cutaneous adverse drug reactions

British Journal of Dermatology

Volumn 139, Issue 1, 1998, Pages 49-58

  Barbaud, A ^a   Reichert Penetrat, S ^a   Trechot P ^a   Jacquin Petit, M A ^a   Ehlinger, A ^a   Noirez, V ^a   Faure, G C ^b   Schmutz, J L ^a   Bene M C ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIODARONE; AMOXICILLIN; ARTICAINE; BETA LACTAM ANTIBIOTIC; CAPTOPRIL; CARBAMAZEPINE; CEFAPIRIN; CEFPODOXIME; CLOXACILLIN; COTRIMOXAZOLE; CYAMEMAZINE; DIHYDROQUINIDINE; DILTIAZEM; DOXYCYCLINE; ENOXAPARIN; ERYTHROMYCIN; FLUVOXAMINE; FUSAFUNGINE; GLIBENCLAMIDE; HEPARIN; ISONIAZID; JOSAMYCIN; NORFLOXACIN; PENICILLIN G; PIPEMIDIC ACID; PIROXICAM; SPIRAMYCIN; TETRAZEPAM; UNINDEXED DRUG;

ADULT; ARTICLE; DRUG ERUPTION; HUMAN; INTRACUTANEOUS TEST; MAJOR CLINICAL STUDY; PATCH TEST; PRACTICE GUIDELINE; PRICK TEST; PRIORITY JOURNAL; SKIN TEST;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; INTRADERMAL TESTS; LACTAMS; MALE; MIDDLE AGED; PATCH TESTS; PROSPECTIVE STUDIES; SKIN TESTS;

EID: 0031821604     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02313.x     Document Type: Article

References (50)

1. Breathnach SM. Mechanisms of drug eruptions. Part 1. Australas J Dermatol 1995; 36: 121-7.
2. de Weck AL. Pharmacologic and immunochemical mechanisms of drug hypersensitivity. Immunol Allergol Clin N Am 1991; 11: 461-74.
3. Barbaud A, Béné M-C, Faure G. Immunological physiopathology of cutaneous adverse drug reactions. Eur J Dermatol 1997; 7: 319-23.
4. Ressler C, Mendelson LM. Skin test for diagnosis of penicillin allergy. Current Status. Ann Allergy 1987; 59: 167-70.
5. Bruynzeel DP, van Ketel WG. Patch testing in drug eruptions. Semin Dermatol 1989; 8: 196-203.
6. Breathnach SM. Management of drug eruptions. Part II. Diagnosis and treatment. Australas J Dermatol 1995; 36: 187-91.
7. Bruynzeel DP, van Ketel WG. Skin tests in the diagnosis of maculopapular drug eruptions. Semin Dermatol 1987; 6: 119-24.
8. Romano A, Di Fonso M. Pietrantonio F et al. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics. Contact Dermatitis 1993; 28: 190.
9. Calkin JM, Maibach H. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993; 29: 223-33.
10. Romano A, Di Fonso M, Papa G et al. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995; 50: 113-18.
11. Bruynzeel DP, von Blomberg-van der Flier M, Scheper RJ et al. Penicillin allergy and the relevance of epicutaneous tests. Dermatologica 1985; 171: 429-34.
12. Barbaud A, Béné M-C. Schmutz J-L et al. Role of delayed cellular hypersensitivity and adhesion molecules in amoxycillin-induced morbilliform rashes. Arch Dermatol 1997; 133: 481-6.
13. Wolkenstein P, Chosidow O, Fléchet M-L et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-6.
14. Osawa J, Naito S, Aihara M et al Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 1990; 17: 235-9.
15. Felix R, Comaish J. The value of the patch tests and other skin tests in drug eruptions. Lancet 1974; i: 1017-19.
16. Moore N, Paux G, Begaud B et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985: ii: 1056-8.
17. Adams RM, Fischer T. Diagnostic patch testing. In: Occupational Skin Diseases (Adams RM, ed.). 2nd edn. Philadelphia: WB Saunders Co., 1990; 223-53.
18. Jeanmougin M. Détermination du pouvoir photosensibilisant d'un médicament par la méthode des photopatch tests. Nouv Dermatol 1986; 5: 204-8.
19. Sacerdoti G, Vozza A, Ruocco V. Identifying skin reactions to drugs. Int J Dermatol 1993; 32: 469-79.
20. Kauppinen K, Alanko K. Oral provocation: uses. Semin Dermatol 1989; 8: 187-91.
21. Michel M, Dompmartin A, Szczurko C et al. Eczematous-like drug eruption induced by synergistins. Contact Dermatitis 1996; 34: 86-7.
22. Jones M, Fernandez-Herrera J, Dorado JM et al. Epicutaneous test in carbamazepine cutaneous reactions. Dermatology 1994; 188: 18-20.
23. Hölzle E, Neumann N, Hausen B et al. Photopatch testing: the 5-year experience of the German, Austrian, and Swiss photopatch test group. J Am Acad Dermatol 1991; 25: 59-68.
24. Menz J, Muller SA, Connolly S. Photopatch testing: a six-year experience. J Am Acad Dermatol 1988; 18: 1044-7.
25. Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-7.
26. Sehgal VN, Gangwani OP. Fixed drug eruption. Current concepts. Int J Dermatol 1987; 26: 67-74.
27. Klein CE, Trautmann A, Zillikens D, Brocker EB. Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis 1995; 33: 448-9.
28. Adkinson NF. Side-chain specific beta-lactam allergy. Clin Exp Allergy 1990; 20: 445-7.
29. Vaillant L. Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 1989; 125: 299.
30. Alanko K. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993; 29: 254-7.
31. Puig L, Nadal C, Fernandez-Figueras M-T, Alomar A. Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation. Contact Dermatitis 1996; 34: 435-7.
32. Ortega NR, Barranco P, Lopez Serrano C et al. Delayed cell-mediated hypersensitivity to tetrazepam. Contact Dermatitis 1996; 34: 139.
33. Bircher AJ. Flückiger R, Buchner SA. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 1990; 123: 507-14.
34. Moreau A, Dompmartin A, Esnault P et al. Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin. Contact Dermatitis 1996; 34: 31-4.
35. Tombs RR, Lepoittevin JP, Espinassouze F et al. Systemic contact dermatitis from pseudoephedrine. Contact Dermatitis 1991; 24: 86-8.
36. Dooms-Goossens A. Allergy to inhaled corticosteroids: a review. Am J Contact Dermatitis 1995; 6: 1-3.
37. Bircher AJ, Pelloni F, Langauer-Messmer S, Müller D. Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes. Br J Dermatol 1996; 135: 310-13.
38. Romano A, Pietrantonio F, Garcovich A et al. Delayed hypersensitivity to diltiazem in two patients. Ann Allergy 1992; 69: 31-2.
39. Michel M, Dompmartin A, Louvet S et al. Skin reactions to hydroxyzine. Contact Dermatitis 1997; 36: 147-9.
40. Romano A, Pietrantonio F, Di Konso M et al. Positivity of patch tests in cutaneous reaction to diclofenac. Allergy 1994; 49: 57-9.
41. Popescu NA, Sheehan MG. Kouides PA et al. Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in live patients. J Allergy Clin Immunol 1996; 97: 26-33.
42. Blanca M, Vega JM. Garcia J et al. Allergy to penicillin with good tolerance to other penicillins: study of the incidence in subjects allergic to betalactams. Clin Exp Allergy 1990; 20: 475-81.
43. Silviu-Dan F, McPhillips S, Warrington R. The frequency of skin test reactions to side-chain penicillin determinants. J Allergy Clin Immunol 1993; 91: 694-701.
44. Audicana M. Bernaola G. Urrutia J et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin. Allergy 1994; 49: 108-13.
45. Barbaud A, Got I, Tréchot P et al. Allergies cutanées et insulinothérapie. Aspects récents, conduite à tenir. Ann Dermatol Venereol 1996; 123: 214-18.
46. Shelley WB, Shelley ED, Talanin NY, Santoso-Pham J. Estrogen dermatitis. J Am Acad Dermatol 1995: 32: 25-31.
47. Vidal C, Tome S, Hernandez-Redondo V, Tato F. Systemic allergic reaction to corticosteroids. Contact Dermatitis 1994; 31: 273-4.
48. Warrington RJ, Silviu-Dan F, Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. J Allergy Clin Immunol 1993; 92: 626-8.
49. Machet L, Vaillant L, Dardaine VF, Lorette G. Patch testing with clobazepam: relapse of generalized drug eruption. Contact Dermatitis 1992; 26: 347-8.
50. Barbaud A. Place of excipients in drug related allergy. Clin Rev Allergol Immunol 1995; 13: 253-63.